Shahriar Sedghi

2.5k total citations
32 papers, 1.1k citations indexed

About

Shahriar Sedghi is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Shahriar Sedghi has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Genetics and 12 papers in Epidemiology. Recurrent topics in Shahriar Sedghi's work include Inflammatory Bowel Disease (13 papers), Microscopic Colitis (7 papers) and Gastroesophageal reflux and treatments (4 papers). Shahriar Sedghi is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Microscopic Colitis (7 papers) and Gastroesophageal reflux and treatments (4 papers). Shahriar Sedghi collaborates with scholars based in United States, Canada and Germany. Shahriar Sedghi's co-authors include Ali Keshavarzian, Ashkan Farhadi, Daniel H. Winship, Manuel I. Doria, J.H. Gordon, Gabrielle Morgan, Ziba Ranjbaran, Edward J. Stepanski, Laurie Keefer and Garth Swanson and has published in prestigious journals such as Gastroenterology, Gut and Journal of Hepatology.

In The Last Decade

Shahriar Sedghi

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shahriar Sedghi United States 12 434 275 237 220 186 32 1.1k
Agata Ptak‐Belowska Poland 23 139 0.3× 173 0.6× 406 1.7× 360 1.6× 107 0.6× 66 1.3k
Maria Słomka Poland 21 80 0.2× 488 1.8× 295 1.2× 269 1.2× 51 0.3× 87 1.4k
R J Vonk Netherlands 22 185 0.4× 227 0.8× 415 1.8× 314 1.4× 271 1.5× 52 1.5k
Hua Gan China 20 179 0.4× 134 0.5× 263 1.1× 464 2.1× 63 0.3× 43 1.2k
E Hvidberg Denmark 19 407 0.9× 292 1.1× 236 1.0× 106 0.5× 65 0.3× 68 1.4k
Xudong Tang China 20 175 0.4× 95 0.3× 259 1.1× 558 2.5× 49 0.3× 112 1.5k
Natalie R. van Zuydam United Kingdom 12 197 0.5× 149 0.5× 153 0.6× 888 4.0× 82 0.4× 15 1.4k
Kenji Watanabe Japan 25 140 0.3× 146 0.5× 148 0.6× 489 2.2× 63 0.3× 128 1.8k
Yusuke Okuyama Japan 19 102 0.2× 131 0.5× 186 0.8× 588 2.7× 40 0.2× 68 1.4k
José D. Torres‐Peña Spain 23 88 0.2× 258 0.9× 147 0.6× 259 1.2× 151 0.8× 72 1.7k

Countries citing papers authored by Shahriar Sedghi

Since Specialization
Citations

This map shows the geographic impact of Shahriar Sedghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahriar Sedghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahriar Sedghi more than expected).

Fields of papers citing papers by Shahriar Sedghi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahriar Sedghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahriar Sedghi. The network helps show where Shahriar Sedghi may publish in the future.

Co-authorship network of co-authors of Shahriar Sedghi

This figure shows the co-authorship network connecting the top 25 collaborators of Shahriar Sedghi. A scholar is included among the top collaborators of Shahriar Sedghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahriar Sedghi. Shahriar Sedghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Poordad, Fred, Shahriar Sedghi, Paul J. Pockros, et al.. (2019). Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis. Journal of Viral Hepatitis. 26(8). 1027–1030. 1 indexed citations
3.
Smith, Katherine E., et al.. (2017). Increasing efficacy and reducing side effects in treatment of chronic anal fissures. Medicine. 96(20). e6853–e6853. 6 indexed citations
4.
Zakko, Salam, Glenn L. Gordon, Uma K. Murthy, et al.. (2016). Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors. Postgraduate Medicine. 128(3). 273–281. 10 indexed citations
5.
Gordon, Glenn L., Salam Zakko, Uma K. Murthy, et al.. (2015). Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis. Journal of Clinical Gastroenterology. 50(4). 318–325. 20 indexed citations
6.
Panaccione, Remo, William J. Sandborn, Glenn L. Gordon, et al.. (2015). Briakinumab for Treatment of Crohnʼs Disease. Inflammatory Bowel Diseases. 21(6). 1–1. 68 indexed citations
7.
Lichtenstein, Gary R., Salam Zakko, Glenn L. Gordon, et al.. (2012). Mesalazine granules 1.5 g once‐daily maintain remission in patients with ulcerative colitis who switch from other 5‐ ASA formulations: a pooled analysis from two randomised controlled trials. Alimentary Pharmacology & Therapeutics. 36(2). 126–134. 8 indexed citations
8.
9.
Swanson, Garth, Shahriar Sedghi, Ashkan Farhadi, & Ali Keshavarzian. (2010). Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol. 44(3). 223–228. 77 indexed citations
10.
Lichtenstein, Gary R., Glenn L. Gordon, Salam Zakko, et al.. (2010). Clinical trial: once‐daily mesalamine granules for maintenance of remission of ulcerative colitis – a 6‐month placebo‐controlled trial. Alimentary Pharmacology & Therapeutics. 32(8). 990–999. 42 indexed citations
11.
Panaccione, Remo, Glenn L. Gordon, Scott Lee, et al.. (2010). Briakinumab (Anti-interleukin 12/23p40, ABT874) for Treatment of Crohnʼs Disease (CD). The American Journal of Gastroenterology. 105. S457–S458. 5 indexed citations
12.
13.
Christie, D. Benjamin, et al.. (2006). Ingested foreign-body retrieval: a novel new method. Gastrointestinal Endoscopy. 65(1). 169–171. 1 indexed citations
14.
Ranjbaran, Ziba, Laurie Keefer, Ashkan Farhadi, et al.. (2006). Impact of sleep disturbances in inflammatory bowel disease. Journal of Gastroenterology and Hepatology. 22(11). 1748–1753. 191 indexed citations
15.
Smith, C. Daniel, et al.. (2004). Comparative results of endoluminal gastroplasty and laparoscopic antireflux surgery for the treatment of GERD. Surgical Endoscopy. 18(2). 261–265. 34 indexed citations
16.
Sedghi, Shahriar, Jeremy Z. Fields, Margaret M. Durkin, et al.. (1993). Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.. Gut. 34(9). 1191–1197. 99 indexed citations
17.
Keshavarzian, Ali, et al.. (1992). Excessive production of reactive oxygen metabolites by inflamed colon: Analysis by chemiluminescence probe. Gastroenterology. 103(1). 177–185. 239 indexed citations
18.
Keshavarzian, Ali, et al.. (1992). Mitomycin C-induced colitis in rats: a new animal model of acute colonic inflammation implicating reactive oxygen species.. PubMed. 120(5). 778–91. 27 indexed citations
19.
Keshavarzian, Ali, et al.. (1991). Effect of Acute Ethanol on Esophageal Motility in Cat. Alcoholism Clinical and Experimental Research. 15(1). 116–121. 16 indexed citations
20.
Keshavarzian, Ali, Gabrielle Morgan, Shahriar Sedghi, J.H. Gordon, & Manuel I. Doria. (1990). Role of reactive oxygen metabolites in experimental colitis.. Gut. 31(7). 786–790. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agata Ptak‐Belowska Breakdown of academic impact, for papers by Maria Słomka Breakdown of academic impact, for papers by R J Vonk Breakdown of academic impact, for papers by Hua Gan Breakdown of academic impact, for papers by E Hvidberg Breakdown of academic impact, for papers by Xudong Tang Breakdown of academic impact, for papers by Natalie R. van Zuydam Breakdown of academic impact, for papers by Kenji Watanabe Breakdown of academic impact, for papers by Yusuke Okuyama Breakdown of academic impact, for papers by José D. Torres‐Peña
Rankless by CCL
2026